Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -24.32%260.95M | -20.18%141.46M | -4.31%344.79M | 9.75%177.21M | 12.91%360.33M | 1.33%161.47M | 2.92%319.13M | 10.63%159.35M | 9.01%310.07M | -2.35%144.03M |
| Operating income | -24.32%260.95M | -20.18%141.46M | -4.31%344.79M | 9.75%177.21M | 12.91%360.33M | 1.33%161.47M | 2.92%319.13M | 10.63%159.35M | 9.01%310.07M | -2.35%144.03M |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Revaluation surplus | 343.84%11M | 63.49%8.1M | 91.33%-4.51M | --4.95M | -1,235.16%-51.99M | ---- | ---3.89M | ---- | ---- | ---- |
| -Changes in the fair value of other assets | 343.84%11M | 63.49%8.1M | 91.33%-4.51M | --4.95M | -1,235.16%-51.99M | ---- | ---3.89M | ---- | ---- | ---- |
| Impairment and provision | 27.15%-100.93M | 39.42%-49.23M | -35.55%-138.54M | -106.96%-81.26M | 28.05%-102.21M | ---39.27M | ---142.05M | ---- | ---- | ---- |
| -Other impairment is provision | 27.15%-100.93M | 39.42%-49.23M | -35.55%-138.54M | -106.96%-81.26M | 28.05%-102.21M | ---39.27M | ---142.05M | ---- | ---- | ---- |
| Special items of operating profit | 1.64%-125.83M | -8.24%-58.88M | -11.10%-127.93M | 11.81%-54.4M | -22.53%-115.15M | -427.12%-61.68M | -1,188.84%-93.98M | 251.25%18.86M | -61.19%8.63M | -62.57%5.37M |
| Operating profit | -38.78%45.19M | -10.88%41.45M | -18.87%73.81M | -23.17%46.5M | 14.86%90.98M | -66.04%60.53M | -75.15%79.21M | 19.28%178.21M | 3.92%318.7M | -7.69%149.4M |
| Share of profits of associates | 8.12%-6.39M | 41.52%-4.09M | 55.61%-6.96M | -72.40%-7M | -57.87%-15.67M | 6.09%-4.06M | -228.52%-9.93M | -395.35%-4.32M | -120.00%-3.02M | -83.33%1.46M |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | 85.76%-18.5M | ---- | -77.52%-129.9M | -6.53%-178.43M | 14.89%-73.18M |
| Earning before tax | -41.97%38.79M | -5.45%37.36M | -11.23%66.85M | 4.05%39.51M | 8.70%75.31M | -13.67%37.97M | -49.52%69.28M | -43.39%43.98M | -11.05%137.25M | -8.22%77.69M |
| Tax | 53.43%-11.19M | 24.79%-11M | 28.15%-24.03M | -38.31%-14.62M | -99.19%-33.45M | 11.52%-10.57M | 58.94%-16.79M | 40.65%-11.95M | -12.92%-40.9M | 5.13%-20.14M |
| After-tax profit from continuing operations | -35.54%27.6M | 5.92%26.36M | 2.29%42.82M | -9.17%24.89M | -20.25%41.86M | -14.47%27.4M | -45.52%52.49M | -44.34%32.03M | -18.40%96.35M | -9.25%57.56M |
| Earning after tax | -35.54%27.6M | 5.92%26.36M | 2.29%42.82M | -9.17%24.89M | -20.25%41.86M | -14.47%27.4M | -45.52%52.49M | -44.34%32.03M | -18.40%96.35M | -9.25%57.56M |
| Minority profit | 2,582.55%17.22M | 71.46%5.6M | -81.46%642K | -57.02%3.27M | -65.06%3.46M | 24.98%7.6M | -31.02%9.91M | -34.88%6.08M | 24.92%14.37M | 30.13%9.34M |
| Profit attributable to shareholders | -75.39%10.38M | -3.99%20.76M | 9.84%42.18M | 9.20%21.62M | -9.82%38.4M | -23.72%19.8M | -48.06%42.58M | -46.18%25.95M | -23.07%81.99M | -14.28%48.22M |
| Basic earnings per share | -66.67%0.01 | 0.00%0.01 | 50.00%0.03 | 0.00%0.01 | -33.33%0.02 | -50.00%0.01 | -40.00%0.03 | -33.33%0.02 | -28.57%0.05 | -25.00%0.03 |
| Diluted earnings per share | -66.67%0.01 | 0.00%0.01 | 50.00%0.03 | 0.00%0.01 | -33.33%0.02 | -50.00%0.01 | -40.00%0.03 | -33.33%0.02 | -28.57%0.05 | -25.00%0.03 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.